A tighter archive for life-science signals.
Search once, then narrow by source or topic.
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth (NASDAQ:TXG) - Seeking Alpha
10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth (NASDAQ:TXG) - Seeking Alpha
Osaic Holdings Inc. Has $1.89 Million Stock Position in 10x Genomics $TXG - MarketBeat
Osaic Holdings Inc. Has $1.89 Million Stock Position in 10x Genomics $TXG - MarketBeat
Assenagon Asset Management S.A. Sells 1,696,984 Shares of 10x Genomics $TXG - MarketBeat
Assenagon Asset Management S.A. Sells 1,696,984 Shares of 10x Genomics $TXG - MarketBeat
Friedenthal Financial Purchases New Holdings in 10x Genomics $TXG - MarketBeat
Friedenthal Financial Purchases New Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Trading Down 4.1% - Should You Sell? - MarketBeat
10x Genomics (NASDAQ:TXG) Trading Down 4.1% - Should You Sell? - MarketBeat
Spatial Transcriptomics Market Size, Trends & Growth Report by 2034 - Straits Research
Spatial Transcriptomics Market Overview The global spatial transcriptomics market size is valued at USD 440.11 million in 2025 and is estimated to reach USD 1,414.13 mi...
Barclays turns more bullish on 10x Genomics, Inc. (TXG) despite uneven research spending - MSN
为了向您提供服务和广告并对其进行维护和改进,微软以及我们的第三方供应商会使用cookies来存储、访问包括唯一识别码(unique ID)等信息。如您同意,微软资讯以及微软必应会向您提供个性化的内容和广告。您可以选择“我同意”从而同意上述使用场景,或者点击“管理设置”查看您的选项以及在适用情况下行使您反对正当利益的权利。您可以通过本页...
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending Published on December 22, 2025 at 10:20 pm by LAIBA IMMAD in Lists, News We rec...
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promisi...
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending Mon, December 22, 2025 at 7:20 PM PST 2 min read We recently compiled a list of...
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending Mon 22 December 2025 at 7:20 pm GMT-8 2 min read We recently compiled a list of...
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
Why 10x Genomics Stock Is Suddenly Surging - TipRanks
Why 10x Genomics Stock Is Suddenly Surging - TipRanks
10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance
10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance
10x Genomics (TXG) Stock Trades Up, Here Is Why - TradingView — Track All Markets
10x Genomics (TXG) Stock Trades Up, Here Is Why - TradingView — Track All Markets
10x Genomics (TXG) Stock Trades Up, Here Is Why - FinancialContent
10x Genomics (TXG) Stock Trades Up, Here Is Why - FinancialContent
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page